Scarica l'app Stockscreener
1.385
11.69%
0.145
Climb Bio Inc Borsa (CLYM) Ultime notizie
Climb Bio Elects New Board Members at Annual Meeting - TipRanks
BNP Paribas Financial Markets Has $69,000 Stock Holdings in Climb Global Solutions, Inc. (NASDAQ:CLMB) - Defense World
This stealth AI supplier just leapfrogged 206 companies on the Fortune 500 - Fortune
Climb Bio (NASDAQ:CLYM) Upgraded at BTIG Research - Defense World
Are Wall Street Analysts Predicting Agilent Technologies Stock Will Climb or Sink? - MSN
Climb Bio Appoints Interim CFO Amid Leadership Change - TipRanks
BTIG sets Climb Bio stock Buy rating, $7 target By Investing.com - Investing.com Nigeria
BTIG sets Climb Bio stock Buy rating, $7 target - Investing.com
BioArctic shares climb on Q1 profit beat, boosted by Bristol payment - Investing.com Canada
Strong week for Access Bio (KOSDAQ:950130) shareholders doesn't alleviate pain of three-year loss - simplywall.st
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
What is Leerink Partnrs’ Estimate for Climb Bio Q2 Earnings? - Defense World
Climb Bio Awards $152K Stock Package to New Executive: Inside the Biotech's Latest Talent Investment - Stock Titan
Climb Bio Reports Increased Losses Amid Ongoing Development - TipRanks
Climb Bio Reports First Quarter 2025 Financial Results and Provides Business Updates - The Manila Times
Tilray Brands Announces the Launch of XMG Atomic Sours: New THC Beverages and Edibles - The Manila Times
Climb Bio reports Q1 EPS (31c) vs (6c) last year - TipRanks
Climb Bio, Inc. SEC 10-Q Report - TradingView
Climb Bio (CLYM) Expected to Announce Earnings on Wednesday - Defense World
Life sciences firms climb after US and China agree to cut tariffs - TradingView
Exec Edge Launches Research Coverage with Initiation Notes on FL - GuruFocus
Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX, ACB - Quantisnow
Market Update: Climb Bio Inc (CLYM) Sees Positive Movement, Closing at 1.21 - DWinneX
Stock Index Futures Climb on U.S.-China Trade Talk Optimism, Fed Rate Decision in Focus - The Globe and Mail
Astaxanthin Market Size to Climb USD 6.86 Billion by 2034 - Precedence Research
Dollar Falls and Gold Prices Climb on US Trade Uncertainty - The Globe and Mail
Jim Cramer on Netflix, Inc. (NFLX): ‘I Bet This One Can Continue to Climb Over the Long Haul’ - Yahoo Finance
Sugar Prices Slump on Expectations for Robust Global Supplies - The Globe and Mail
Kospi continues to climb gradually amid auto and bio gains - MSN
Stock market today: Dow extends longest win streak of 2025 as S&P 500, Nasdaq climb after latest tariff relief - Yahoo Finance
Tevogen Bio Holdings Stock Is Soaring After Hours: What's Going On? - Benzinga
F5 shares climb after earnings and revenue exceed analyst forecasts - SiliconANGLE
Hair Transplant System Market Expected to Climb to USD 44.24 Billion by 2032, Rising at 21.6% CAGR - openPR.com
Piper Sandler Remains a Buy on Solid Biosciences (SLDB) - The Globe and Mail
Virtual Cardiology Market Expected to Climb from USD 1.7 Billion in 2025 to USD 4.2 Billion by 2032 - openPR.com
Climb Bio Inc (NASDAQ: CLYM): On Track To A Higher Share Price - Stocksregister
Most active stocks: US stocks with the highest trading volume today - Yahoo
Sugar Prices Climb on Reduced Sugar Output in India - The Globe and Mail
UnitedHealth reports 'unusual and unacceptable' earnings as Medicare costs climb - Endpoints News
Netflix Stock Extends Recent Climb Ahead of Earnings Release - Investopedia
Enterprise AI Breakthrough: New Partnership Promises Hours-Fast Implementation for Fortune 500 Companies - Stock Titan
3,756 Shares in Climb Global Solutions, Inc. (NASDAQ:CLMB) Purchased by Arrowstreet Capital Limited Partnership - Defense World
12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga
Exec Edge Launches Research Coverage with Initiation Notes on FLD, CLYM, STKS, REX - Yahoo Finance
Happy Joe’s, Sacco climb top industry Movers & Shakers list - Quad Cities Business Journal
CLYM stock touches 52-week low at $1.2 amid market challenges - Investing.com Australia
Climb Bio expands board with two new directors - Investing.com Australia
Climb Bio expands board with two new directors By Investing.com - Investing.com Canada
Climb Bio appoints Kim Cobleigh Drapkin, Bo Cumbo to board - TipRanks
Climb Bio Expands Board with New Director Appointments - TipRanks
Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors - The Manila Times
INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL Phase II Study - The Manila Times
Biotech Leaders Join Climb Bio Board: 11 Successful Drug Launches Experience - Stock Titan
Q2 Earnings Estimate for Climb Bio Issued By Leerink Partnrs - The AM Reporter
1.30%
3.35%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):